Thomas Bures
Chief Accounting Officer at Bruker Corp (BRKR) since January 2025
Thomas Bures has filed 8 insider reports with the SEC since March 2021, as chief Accounting Officer at Bruker Corp (BRKR) and officer at Pieris Pharmaceuticals, Inc. (PVLA). Thomas Bures made no open-market purchases or sales in the last 12 months. The latest filing, on August 18, 2026, reports grant or award at Bruker Corp (BRKR).
- Filings
- 8
- Companies
- 2
- Bought on market
- $23.7K
- Sold on market
- None
Companies where Thomas Bures is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Accounting Officersince January 2025 | 7,233 | $23.7K | $47.40 | $56.46+19% | Aug 18, 2026 | ||
| Officer | $142.85 | Feb 28, 2023 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Aug 15, 2026BRKRChief Accounting Officer Bures Thomas was granted 4,035 shares, increasing direct ownership by 126% to 7,233 unitsForm 4Grant or award
- Feb 15, 2026BRKRChief Accounting Officer Bures Thomas covered exercise/tax liability with 274 shares, decreasing direct ownership by 8% to 3,198 unitsForm 4Shares withheld for taxes or exercise price
- Mar 10, 2025+$23.7KBRKRChief Accounting Officer Bures Thomas bought $23,698 worth of shares (500 units at $47.40), increasing direct ownership by 17% to 3,472 unitsForm 4Open-market purchase
- Feb 15, 2025BRKRChief Accounting Officer Bures Thomas was granted 2,972 sharesForm 4Grant or award
- Jan 13, 2025BRKRThomas Bures became an insiderForm 3New insider
- Feb 24, 2023PVLASEC Form 4 filed by Bures ThomasForm 4Grant or award
- Feb 22, 2022PVLASEC Form 4 filed by Bures ThomasForm 4Grant or award
- Mar 4, 2021PVLASEC Form 4 filed by Thomas BuresForm 4Grant or award
Compare Thomas Bures with
- Thomas Bures vs Jeffrey S Martini1 shared
- Thomas Bures vs Kathleen Goin1 shared
- Thomas Bures vs Mark Munch1 shared
- Thomas Bures vs George M Jenkins1 shared
- Thomas Bures vs Christopher P Kiritsy1 shared
- Thomas Bures vs Frank H Laukien1 shared
Other insiders at the same companies
- Jeffrey S MartiniPVLA
- Kathleen GoinPVLA
- Mark MunchBRKR
- George M JenkinsPVLA
- Christopher P KiritsyPVLA
- Frank H LaukienBRKR
- Wolfgang PuschBRKR
- Juergen SregaBRKR
- Burkhard PrauseBRKR
- Gerald N HermanBRKR
- Matthew PaulsPVLA
- Matthew E KorenbergPVLA
- Elaine J HeronPVLA
- John DouxPVLA
- Todd C DavisPVLA
- Tadd S. WesselPVLA
Questions about Thomas Bures
- What is Thomas Bures's role at Bruker Corp?
- Thomas Bures reports to the SEC as chief Accounting Officer at Bruker Corp (BRKR), according to the latest filing on August 18, 2026. Thomas Bures has also filed as officer at Pieris Pharmaceuticals, Inc. (PVLA).
- How many shares does Thomas Bures own?
- After the latest filing that states it, Thomas Bures directly owned 7,233 shares of Bruker Corp (BRKR). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Thomas Bures bought or sold stock recently?
- The most recent open-market purchase was on March 10, 2025: bought 500 shares of Bruker Corp (BRKR) for $23.7K at an average of $47.40.
- How do I get alerts when Thomas Bures files?
- Follow Thomas Bures on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Thomas Bures (SEC CIK 0001787029). Totals count each trade once, skipping amendments whose original is on file, from Mar 8, 2021 on. View on SEC EDGAR · Get this as JSON